Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cardio Diagnostics Holdings (CDIO) Depreciation and Depletion (2023 - 2025)

Cardio Diagnostics Holdings' Depreciation and Depletion history spans 3 years, with the latest figure at $40402.0 for Q3 2025.

  • For Q3 2025, Depreciation and Depletion rose 9.9% year-over-year to $40402.0; the TTM value through Sep 2025 reached $153279.0, up 94.63%, while the annual FY2024 figure was $113777.0, 2902.03% up from the prior year.
  • Depreciation and Depletion for Q3 2025 was $40402.0 at Cardio Diagnostics Holdings, up from $37785.0 in the prior quarter.
  • Across five years, Depreciation and Depletion topped out at $40402.0 in Q3 2025 and bottomed at $1377.0 in Q3 2023.
  • The 3-year median for Depreciation and Depletion is $36762.0 (2024), against an average of $25934.4.
  • The largest annual shift saw Depreciation and Depletion soared 2569.72% in 2024 before it grew 4.98% in 2025.
  • A 3-year view of Depreciation and Depletion shows it stood at $2413.0 in 2023, then surged by 1451.43% to $37436.0 in 2024, then rose by 7.92% to $40402.0 in 2025.
  • Per Business Quant, the three most recent readings for CDIO's Depreciation and Depletion are $40402.0 (Q3 2025), $37785.0 (Q2 2025), and $37656.0 (Q1 2025).